Safety Study of GRNOPC1 in Spinal Cord Injury

Trial ID or NCT#

NCT01217008

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of the study is to evaluate the safety of GRNOPC1 administered at a single time-point between 7 and 14 days post injury, inclusive, to patients with neurologically complete spinal cord injuries (SCI).

Investigator(s)

Gary K. Steinberg, MD, PhD